СПОСОБ ОДНОВРЕМЕННОГО ОБНАРУЖЕНИЯ МИКОБАКТЕРИЙ ТУБЕРКУЛЕЗНОГО КОМПЛЕКСА И ИДЕНТИФИКАЦИИ МУТАЦИЙ В ДНК МИКОБАКТЕРИЙ, ПРИВОДЯЩИХ К УСТОЙЧИВОСТИ МИКРООРГАНИЗМОВ К РИФАМПИЦИНУ И ИЗОНИАЗИДУ, НА БИОЛОГИЧЕСКИХ МИКРОЧИПАХ, НАБОР ПРАЙМЕРОВ, БИОЧИП И НАБОР ОЛИГОНУКЛЕОТИДНЫХ ЗОНДОВ, ИСПОЛЬЗУЕМЫЕ В СПОСОБЕ

摘要

The present invention relates to molecular biology, microbiology, and medicine and provides the method for detection of Mycobacterium tuberculosis complex with simultaneous evaluation of sensitivity of the strains to rifampicin and isoniazid in clinical sample on differentiating biochip. The method is based on two-stage multiplex PCR to obtain fluorescent DNA fragments followed by hybridization of these fragments on microarray containing the set of specific discriminating oligonucleotides. The determination of the resistance of Mycobacterium tuberculosis to rifampicin and isoniazid is carried out by evaluation of point nucleotide substitutions in DNA of microorganism. The present invention allows conduct analysis directly in clinical sample, to evaluate a number of mutations simultaneously, to decrease the cost price of analysis, and to reduce the time of its conducting. The present invention also relates to set of primers, biochip, and set of oligonucleotide probes used in realization of the method.